🇺🇸 FDA
Patent

US 7329652

Diaminotriazole compounds useful as protein kinase inhibitors

granted A61PA61P11/06A61P21/00

Quick answer

US patent 7329652 (Diaminotriazole compounds useful as protein kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P11/06, A61P21/00, A61P25/00, A61P29/00